Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced a new investment into a RMB400 million structured deposit with the Bank of China Deposit, bringing their total structured deposits to RMB850 million. This financial move is considered a discloseable transaction due to its size, requiring public disclosure and reporting. The structured deposit, offering a floating return rate and principal guarantee, demonstrates the company’s ongoing financial strategies and asset management.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.